Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations.

[1]  R. Iles,et al.  Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi's sarcoma: is there a connection? , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  A. Balen,et al.  Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins? , 2002, Human reproduction.

[3]  L. O’Dea,et al.  Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. , 2001, Fertility and sterility.

[4]  L. Cole,et al.  Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. , 2001, Clinical chemistry.

[5]  H. D. de Bruijn,et al.  Eosinophil derived neurotoxin (EDN) levels in commercial human urinary preparations of glycoprotein hormones. , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[6]  R. Gallo,et al.  Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone , 1995, Nature.

[7]  G. K. Scott,et al.  The detection and isolation of protease activity associated with purified preparations of human chorionic gonadotropin. , 1993, Endocrinology.

[8]  H. Watanabe.  Epidermal growth factor in urine of pregnant women and in amniotic fluid throughout pregnancy. , 1990, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[9]  K. Schulz,et al.  Characterization of epidermal growth factor-related proteins from human urinary chorionic gonadotrophin. , 1989, Journal of Endocrinology.

[10]  J. Harrington,et al.  Heterogeneity of proteins in commercial preparations of human chorionic gonadotropin (hCG) demonstrated by Western blotting. , 1988, American journal of reproductive immunology and microbiology : AJRIM.

[11]  B. Rolfe,et al.  Early pregnancy factor is an immunosuppressive contaminant of commercial preparations of human chorionic gonadotrophin. , 1983, Clinical and experimental immunology.

[12]  G. Knox,et al.  Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparations. , 1978, The Journal of clinical investigation.